Corrigendum to "The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management" [Thromb. Res., 194, October 2020, Pages 101-115].
作者信息
Abou-Ismail Mouhamed Yazan, Diamond Akiva, Kapoor Sargam, Arafah Yasmin, Nayak Lalitha
机构信息
University Hospitals, Cleveland Medical Center, Cleveland, OH, United States of America; Case Western Reserve University, Cleveland, OH, United States of America.
University Hospitals, Cleveland Medical Center, Cleveland, OH, United States of America; Case Western Reserve University, Cleveland, OH, United States of America.
出版信息
Thromb Res. 2021 Aug;204:146. doi: 10.1016/j.thromres.2020.11.012. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
Corrigendum to "The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management" [Thromb. Res., 194, October 2020, Pages 101-115].《COVID-19中的高凝状态：发病率、病理生理学及管理》勘误[《血栓研究》，第194卷，2020年10月，第101 - 115页]
Thromb Res. 2021 Aug;204:146. doi: 10.1016/j.thromres.2020.11.012. Epub 2020 Nov 27.
2
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
Thromb Res. 2020 Jul;191:156-159. doi: 10.1016/j.thromres.2020.02.022. Epub 2020 Mar 6.
3
Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
Thromb Res. 2020 Dec;196:641. doi: 10.1016/j.thromres.2020.10.001. Epub 2020 Oct 13.
4
Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
Thromb Res. 2022 Jan;209:105. doi: 10.1016/j.thromres.2021.11.022. Epub 2021 Dec 15.
5
Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].
Thromb Res. 2016 Oct;146:135. doi: 10.1016/j.thromres.2016.09.008. Epub 2016 Sep 16.
6
Corrigendum to "Delayed time to emergency hip surgery in patients taking oral anticoagulants" [Thromb Res. 184 (2019 Dec) 110-114].
Thromb Res. 2020 Jan;185:183. doi: 10.1016/j.thromres.2019.12.001. Epub 2019 Dec 9.
7
Corrigendum to "Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation" [Thromb. Res. 166 (2018) 113-121].
Thromb Res. 2018 Nov;171:200. doi: 10.1016/j.thromres.2018.05.033. Epub 2018 Jun 8.
8
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?" [Thromb. Res. 236 (2024) 236-239 TR_8963].《房颤中的阿孙地昔：药效学数据能否解释其失败原因？》勘误 [《血栓研究》236 (2024) 236 - 239，TR_8963]
Thromb Res. 2024 Aug;240:109066. doi: 10.1016/j.thromres.2024.109066. Epub 2024 Jun 18.
9
Corrigendum to "Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura" [Thromb. Res. 133 (2014) 616-621].
Thromb Res. 2016 May;141:145. doi: 10.1016/j.thromres.2016.03.023. Epub 2016 Apr 2.
10
Corrigendum to "Transplantation of VEGFl65-overexpressing vascular endothelial progenitor cells relieves endothelial injury after deep vein thrombectomy" [Thromb. Res. 137 (2016) 41-45].
Thromb Res. 2017 Jun;154:107. doi: 10.1016/j.thromres.2017.04.026. Epub 2017 May 7.
引用本文的文献
1
Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series.遗传性血栓形成倾向作为COVID-19严重疾病的可能危险因素：病例系列
Forensic Sci Med Pathol. 2025 Mar;21(1):260-266. doi: 10.1007/s12024-024-00879-4. Epub 2024 Sep 27.
2
Comparison between D-dimer levels in diabetic and non-diabetic positive COVID-19 adult patients: A hospital-based study.糖尿病与非糖尿病成年 COVID-19 阳性患者的 D-二聚体水平比较：一项基于医院的研究。
Endocrinol Diabetes Metab. 2022 Jul;5(4):e349. doi: 10.1002/edm2.349. Epub 2022 May 25.
3
Necrotizing pancreatitis with portal vein thrombosis in young patient with COVID-19.COVID-19 年轻患者合并坏死性胰腺炎和门静脉血栓形成。
J Infect Public Health. 2022 Apr;15(4):433-436. doi: 10.1016/j.jiph.2022.03.009. Epub 2022 Mar 19.
Zotero 插件